SG48755A1 - Indane derivative and processes for preparing the same - Google Patents

Indane derivative and processes for preparing the same

Info

Publication number
SG48755A1
SG48755A1 SG1996001274A SG1996001274A SG48755A1 SG 48755 A1 SG48755 A1 SG 48755A1 SG 1996001274 A SG1996001274 A SG 1996001274A SG 1996001274 A SG1996001274 A SG 1996001274A SG 48755 A1 SG48755 A1 SG 48755A1
Authority
SG
Singapore
Prior art keywords
preparing
processes
same
group
indane derivative
Prior art date
Application number
SG1996001274A
Other languages
English (en)
Inventor
Akihiko Ishida
Koichi Homma
Michihisa Yato
Shinsuke Nishiyama
Fumikazu Okumura
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of SG48755A1 publication Critical patent/SG48755A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1996001274A 1993-12-28 1994-12-27 Indane derivative and processes for preparing the same SG48755A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP33525093 1993-12-28

Publications (1)

Publication Number Publication Date
SG48755A1 true SG48755A1 (en) 1998-05-18

Family

ID=18286423

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996001274A SG48755A1 (en) 1993-12-28 1994-12-27 Indane derivative and processes for preparing the same

Country Status (11)

Country Link
US (1) US5686452A (fr)
EP (1) EP0661273B1 (fr)
KR (1) KR950017968A (fr)
CN (1) CN1107844A (fr)
AT (1) ATE180251T1 (fr)
CA (1) CA2138812A1 (fr)
DE (1) DE69418582D1 (fr)
DK (1) DK0661273T3 (fr)
MX (1) MX9500251A (fr)
SG (1) SG48755A1 (fr)
TW (1) TW288012B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118631A (en) * 1995-06-27 2002-05-23 Tanabe Seiyaku Co History of pyridazinone and processes for their preparation
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
EP2328586A2 (fr) * 2008-05-20 2011-06-08 Cephalon, Inc. Dérivés pyridazinone substitués comme ligands des récepteurs de l'histamine-3 (h3)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4816454A (en) * 1984-09-21 1989-03-28 Cassella Aktiengesellschaft 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use
EP0194548A3 (fr) * 1985-03-12 1988-08-17 Dr. Karl Thomae GmbH Composés sulfonylaminoéthyl, médicament contenant ces composés et leur procédé de préparation
DE3623944A1 (de) * 1986-07-16 1988-02-11 Thomae Gmbh Dr K Neue benzolsulfonamido-indanylverbindungen, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
IL88314A (en) * 1987-11-18 1994-05-30 Tanabe Seiyaku Co History of sulfonylamino indane, their preparation and pharmaceutical preparations containing them
AU651182B2 (en) * 1991-03-01 1994-07-14 Zeria Pharmaceutical Co., Ltd. Indan derivative and thromboxane antagonist containing the same
CA2099743A1 (fr) * 1992-07-02 1994-01-03 Akihiko Ishida Derives de la pyridazinone et procedes pour leur preparation
CA2139088A1 (fr) * 1993-12-28 1995-06-29 Akihiko Ishida Derives indane, procedes pour leur preparation et intermediaires synthetiques pour ceux-ci

Also Published As

Publication number Publication date
ATE180251T1 (de) 1999-06-15
DE69418582D1 (de) 1999-06-24
MX9500251A (es) 1997-04-30
EP0661273B1 (fr) 1999-05-19
KR950017968A (ko) 1995-07-22
EP0661273A1 (fr) 1995-07-05
CN1107844A (zh) 1995-09-06
CA2138812A1 (fr) 1995-06-29
TW288012B (fr) 1996-10-11
US5686452A (en) 1997-11-11
DK0661273T3 (da) 1999-11-08

Similar Documents

Publication Publication Date Title
EP0705833A4 (fr) Derive de dc-89
GR3025715T3 (en) Azolylamine derivative
AU9281198A (en) Benzofuran derivatives
HU912649D0 (en) New tricyclic compounds production threreof and anti-microbic preparatives
HU9502270D0 (en) Novel pyrrolocarbazoles
HK1031867A1 (en) 2-phenoxyaniline derivatives
IL134788A0 (en) A process for preparing 2-alkyl-3-aminothiophene derivatives
EP0601191A4 (en) Novel tetracyclic compound.
TW288012B (fr)
EP0626369A4 (fr) Derive de benzenesulfonamide.
GB2190587B (en) Prophylactic and curing composition for arteriosclerosis
EP0573659A4 (en) Pyrazolothiazolopyrimidine derivative
EP0614897A4 (fr) Derive d'imidazonaphtyridine.
EP0648743A4 (fr)